Masahiro Kawabata mostly deals with SMAD, Bone morphogenetic protein, Molecular biology, Cell biology and Mothers against decapentaplegic homolog 3. SMAD is a subfield of Biochemistry that he studies. His work on BMPR2 and Bone morphogenetic protein receptor as part of his general Bone morphogenetic protein study is frequently connected to Bone morphogenetic protein 2 and Osteoblast, thereby bridging the divide between different branches of science.
His Molecular biology research is multidisciplinary, incorporating elements of Receptor, Core binding factor and Mitogen-activated protein kinase kinase. His work on Thioredoxin expands to the thematically related Cell biology. His research in the fields of Kinase activity overlaps with other disciplines such as Inhibitor of apoptosis.
Cell biology, Molecular biology, SMAD, Signal transduction and Bone morphogenetic protein are his primary areas of study. His research integrates issues of Receptor, Receptor complex and Endocrinology in his study of Cell biology. His studies in Molecular biology integrate themes in fields like Amino acid, Mothers against decapentaplegic homolog 2, Transcription factor, DNA and Binding site.
His study in the fields of Mothers against decapentaplegic homolog 3 under the domain of SMAD overlaps with other disciplines such as R-SMAD. The Transforming growth factor beta and STAT3 research Masahiro Kawabata does as part of his general Signal transduction study is frequently linked to other disciplines of science, such as Inhibitor of apoptosis, therefore creating a link between diverse domains of science. When carried out as part of a general Bone morphogenetic protein research project, his work on BMPR2 and Bone morphogenetic protein 10 is frequently linked to work in Bone morphogenetic protein 2, GDF2 and Osteoblast, therefore connecting diverse disciplines of study.
Masahiro Kawabata mainly investigates Cell biology, Signal transduction, SMAD, Cancer research and Molecular biology. His Cell biology research incorporates themes from HMG-box, bZIP domain and Binding domain, Binding site. As a part of the same scientific study, he usually deals with the Signal transduction, concentrating on Transforming growth factor and frequently concerns with Coactivator, Transactivation, Calcitriol receptor, Long-term potentiation and Vitamin D and neurology.
His SMAD research includes themes of Cellular differentiation and Protein kinase A. His study focuses on the intersection of Cancer research and fields such as Regulation of gene expression with connections in the field of STAT3, Activator, STAT3 Transcription Factor, Hepatic stellate cell and Cytokine. In his research on the topic of Molecular biology, Mothers against decapentaplegic homolog 3 is strongly related with Bone morphogenetic protein.
His primary areas of study are Cell biology, Signal transduction, SMAD, Ubiquitin and Ubiquitin ligase complex. Masahiro Kawabata has included themes like Long-term potentiation and Bone morphogenetic protein in his Cell biology study. Masahiro Kawabata combines subjects such as Transforming growth factor, Endocrinology, Coactivator, Transactivation and Calcitriol receptor with his study of Long-term potentiation.
Calcitriol receptor is a subfield of Vitamin D and neurology that Masahiro Kawabata tackles. He has researched Bone morphogenetic protein in several fields, including Molecular biology, Transcription factor, CREB and Protein kinase A. His Ubiquitin research is multidisciplinary, relying on both Transforming growth factor beta, DNA-binding protein and Phosphorylation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
Masao Saitoh;Hideki Nishitoh;Makiko Fujii;Kohsuke Takeda.
The EMBO Journal (1998)
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Atsuhito Nakao;Mozhgan Afrakhte;Anita Morn;Takuya Nakayama.
Smad6 inhibits signalling by the TGF-Beta superfamily
Takeshi Imamura;Masao Takase;Ayako Nishihara;Eiichi Oeda.
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata.
The EMBO Journal (1997)
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.
Kinichi Nakashima;Makoto Yanagisawa;Hirokazu Arakawa;Naoki Kimura.
Signal transduction by bone morphogenetic proteins.
Masahiro Kawabata;Takeshi Imamura;Kohei Miyazono.
Cytokine & Growth Factor Reviews (1998)
Convergence of Transforming Growth Factor-β and Vitamin D Signaling Pathways on SMAD Transcriptional Coactivators
Junn Yanagisawa;Yasuo Yanagi;Yoshikazu Masuhiro;Miyuki Suzawa.
Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation
M Fujii;K Takeda;T Imamura;H Aoki.
Molecular Biology of the Cell (1999)
BMP type II receptor is required for gastrulation and early development of mouse embryos.
Hideyuki Beppu;Masahiro Kawabata;Toshiaki Hamamoto;Anna Chytil.
Developmental Biology (2000)
Interaction and Functional Cooperation of PEBP2/CBF with Smads SYNERGISTIC INDUCTION OF THE IMMUNOGLOBULIN GERMLINE Cα PROMOTER
Jun Ichi Hanai;Lin Feng Chen;Tomohiko Kanno;Naoko Ohtani-Fujita.
Journal of Biological Chemistry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: